Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in Preconception
Launched by UNIVERSITÉ DE SHERBROOKE · Jan 22, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Summary of the Healthy for My Baby Clinical Trial**
The "Healthy for My Baby" study is looking to help overweight women and their partners who want to have a baby within the next year. The goal is to see if a special program that includes motivational support and a mobile app can encourage them to adopt healthier lifestyle habits before conception. This program will not only focus on helping the women and their partners make positive changes, but it will also track how these changes affect their weight, body measurements, and overall health. Additionally, the study will follow them during pregnancy to understand how these lifestyle improvements might impact weight gain during pregnancy, any pregnancy complications, and the health of their baby at birth.
To participate in this trial, women need to be overweight (with a body mass index of 25 or higher) and have a partner who is also interested in having a child in the near future. They should also have a smartphone to use the app. However, some individuals won't be eligible, such as those with certain medical conditions, a history of infertility, or who are currently involved in other similar lifestyle programs. Participants can expect to receive tailored support and resources to help them on their journey toward healthier living as they prepare for pregnancy. This study may provide valuable insights into how lifestyle changes can benefit both parents and their future children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Women and their partner who wish to conceive within 12 months of trial inclusion
- • Woman's body mass index ≥ 25 kg/m2
- • Access to a smart phone
- Exclusion Criteria:
- • Insufficient knowledge of French or English
- • Anticipated move to another region
- • Personal history of infertility
- • Type 1 or 2 diabetes mellitus
- • Prior bariatric surgery
- • Active eating disorder established by clinical diagnosis
- • Medical contraindication to pregnancy
- • Medical contraindication to physical activity
- • Participation in another intensive lifestyle intervention
- • Known or anticipated disease or surgery likely to cause an important weight loss
- • Multiple pregnancies will be excluded from the pregnancy follow-up to limit aberrant data
About Université De Sherbrooke
The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, Quebec, Canada
Québec, , Canada
Québec, Quebec, Canada
Patients applied
Trial Officials
William D Fraser, MD,MSc
Principal Investigator
Researcher, Centre de recherche du CHUS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials